维普中文期刊产品整合服务
192篇 您的检索式:作者名="Ostergren"
    题名 作者 年代 出处 被引量
1雷米普利预防脑卒中:随机双盲试验显示文摘目的 :评价血管紧张素转换酶抑制剂 (ACEI)雷米普利 (ramipril)在脑卒中二级预防中的作用。试验设计 :随机对照 2× 2析因设计。组织 :19个国家的 2 67家医院。入选者 :92 97例患者 ,均有血管疾病或合并有一个危险因素的糖尿病患者 ,随访 4 5年。其为HOPE试验的一个组成部分。观察指标 :脑卒中 (有条件时 ,由CT或MRI证实 )、短暂脑缺血发作 (TIA)、认知功能障碍。在患者入选时、2年时及终点时记录血压。结果 :应用雷米普利使血压轻度下降 (平均收缩压降低 3 8mmHg,舒张压降低 2 8mmHg)。应用雷米普利组比安慰剂组脑卒中相对危险度下降 3 2 % (15 6比 2 2 6) ,致死性脑卒中下降 5 1%(17比 44 )。不管患者的基线血压水平高低、是否应用其他药物 ,以及有无脑卒中史、冠心病、外周动脉疾病、糖尿病或高血压 ,应用雷米普利受益是一致的。雷米普利组大脑认知或功能障碍者明显少于安慰剂组。结论 :雷米普利尽管使血压轻度降低 ,却使高危患者的脑卒中发生率明显下降。Jackie Bosch Salim Yusuf Janice Pogue Peter Sleight Eva Lonn Badrudin Rangoonwala Richard Davies Jan Ostergren Jeff Probstfield 高展 2002英国医学杂志中文版2002,5,4:4
2Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking ACEI:the CHARM-Added trial显示文摘 Ostergren J Swedberg K 2003Lancet2003,362,:1
3Candesartan for the treatment of hypert- ension and heart failure显示文摘OSTERGREN J 2004Exp Opin Pharmacother2004,5,7:1
4Cystatin C-a marker of peripheral atherosclerotic disease?显示文摘Arpegard J Ostergren J de Faire U 2008Atherosclerosis2008,199,2:1
5Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM- Added trial显示文摘McMurray J J Ostergren J Swedberg K 2003Lancet2003,362,:1
6Amino-termi- nal pro-B-type natriuretic Peptide and high-sensitivity C-reac- tive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure 显示文摘Skoglund P H Arpegard J Ostergren J 2014Am J Hypertens2014,27,3:1
7Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin- converting-enzyme inhibitors : the CHARM-Added trial 显示文摘MCMURRAY J J OSTERGREN J SWEDBERG K 2003Lancet2003,362,9386:1
8Small scale yielding near a crack in plane strain: A finite element analysis显示文摘N. Levy P. V. Marcal W. J. Ostergren J. R. Rice 1971International Journal of Fracture Mechanics1971,,2:1
9Cystatin C a marker of peripheral atherosclerotic disease显示文摘Arpegard J Ostergren J de Faire U 2008Atherosclerosis2008,199,2:1
10Left ventricular mass is not related to insulin sensitivity in never-treated primary hypertension 显示文摘Malmqvist K Isaksson H Ostergren J 2001J Hypertens2001,19,2:1
11Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure:Assessment of Reduction in Mortality and Morbidity) Program显示文摘Meredith PA Ostergren J Anand I 2008J Am Coll Cardiol2008,52,24:1
12Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients with Heart Failure显示文摘Yusuf S Ostergren JB Gerstein HC 2005Circulation2005,112,1:1
13A damage function and associated fail- ure equation for predicting hold time and frequency effects in elevated temperature low cycle fatigue 显示文摘OSTERGREN W J 1976Journal of Testing and Evaluation1976,4,5:1
14Life-course perspective on socioeconomic differences in carotid atherosclerosis显示文摘Rosvall M Ostergren PO Hedblad B 2002Arterioscler Thromb Vasc Biol2002,22,10:1
15Exhaustion predicts coro- nary heart disease independently of symptoms of depression and anxiety in men but not in women 显示文摘Lindeberg S I Rosvall M Ostergren P O 2012Journal of Psychosomatic Re search2012,72,1:1
16Social class and cardiovascu-lar disease-an update显示文摘Nilsson PM Moller L Ostergren PO 1995Scand J Soc Med1995,23,1:1
17Parental economic stress: evidence of an overlooked public health risk among Swedish families 显示文摘01ivius G Ostergren PO Hanson BS 2004Eur J Public Health2004,14,4:1
18Effects of candesartan in patients with chronic heart failure and reduced left ventricular systolic function taking angiotensin-converting-enzyme inhibitors:the CHARM-Added trial显示文摘McMurray JJ Ostergren J Swedberg K 2003Lancet2003,362,9386:1
19The Anglo - scandinavia ardciac outcomes trial: Blood press - lowing limb~ Effects in pa- tients with Type ]I diabetes显示文摘Ostergren J Pouher NR Sever PS eZ al 2008J Hypertens2008,26,:1
20Effects of candesartan in patients with chronic heart failure and reduced left ventricular systolic function taking angiotensin-converting enzyme inhibitor: the CHARM-Added trial 显示文摘Memurray JJ Ostergren J Swedberg K 2003The Lancet2003,362,9386:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费